Melanotan II Research Guide
Research Overview
Melanotan II is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that has been studied for its interaction with the melanocortin receptor family in laboratory settings. It is not an approved product and is handled strictly as a research compound, not intended for human consumption. Research interest has centered on characterizing its non-selective melanocortin-receptor binding profile in preclinical models.
Structural & Class Overview
Synthetic cyclic heptapeptide; alpha-MSH analog within the melanocortin agonist family. Reported in the literature as a non-selective agonist across melanocortin receptor subtypes MC1R, MC3R, MC4R, and MC5R. Molecular formula C50H69N15O9; CAS 121062-08-6; referenced under PubChem records for melanotan II.
General Research Interest
Research interest includes characterization of MC1R-mediated melanogenesis signaling pathways in cell-based assays; investigation of MC4R signaling in preclinical models of feeding behavior and energy homeostasis; study of MC3R/MC4R contributions to central nervous system melanocortin activity; structure-activity relationship comparisons among cyclic alpha-MSH analogs; and receptor-binding affinity profiling in laboratory settings.
Storage Considerations
General research-handling guidance for a lyophilized peptide: store the sealed lyophilized powder cold (commonly refrigerated or frozen per supplier documentation), protected from light and moisture. Once reconstituted for laboratory work, keep refrigerated and minimize freeze-thaw cycles. For research use only; not for human or veterinary use.
Testing & Quality Considerations
Quality considerations for a research peptide include reversed-phase HPLC assessment of purity, mass spectrometry for identity and molecular-weight confirmation, and review of a batch-specific Certificate of Analysis (COA).
References
- Melanotan II — Wikipedia (structural and pharmacological overview)
- Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens (PubMed)
References are provided for scientific context. Linked sources are independent and not affiliated with iNGEN MD.
